EGF and breast carcinoma: By taking this general approach of Ras hyper-activation, we have recapitulated the excessive activation of the Ras pathway in breast cancer, which is induced in patients by multiple RTK ligands such as epidermal growth factor (EGF) [1,27,28,47,48].